12:00 AM
 | 
Feb 02, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Formoterol Modulite regulatory update

EMEA's CHMP recommended against use of Chiesi's formoterol 12 µg to treat asthma in children ages 5-12 years...

Read the full 66 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >